BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37127632)

  • 21. A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial.
    Kassimatis T; Qasem A; Douiri A; Ryan EG; Rebollo-Mesa I; Nichols LL; Greenlaw R; Olsburgh J; Smith RA; Sacks SH; Drage M
    Trials; 2017 Jun; 18(1):255. PubMed ID: 28587616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic mesenchymal stem cell as induction therapy to prevent both delayed graft function and acute rejection in deceased donor renal transplantation: study protocol for a randomized controlled trial.
    Sun Q; Hong L; Huang Z; Na N; Hua X; Peng Y; Zhao M; Cao R; Sun Q
    Trials; 2017 Nov; 18(1):545. PubMed ID: 29145879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective, randomized, single-blind, multicentre, phase III study on organ preservation with Custodiol-N solution compared with Custodiol® solution in organ transplantation (kidney, liver and pancreas).
    Kniepeiss D; Houben P; Stiegler P; Berghold A; Riedl R; Kahn J; Schemmer P
    Trials; 2020 Jan; 21(1):62. PubMed ID: 31924234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulsatile perfusion preservation for expanded-criteria donors kidneys: Impact on delayed graft function rate.
    Abboud I; Antoine C; Gaudez F; Fieux F; Lefaucheur C; Pillebout E; Viglietti D; Serrato T; Vérine J; Flamant M; Peraldi MN; Glotz D
    Int J Artif Organs; 2011 Jun; 34(6):513-8. PubMed ID: 21725933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cold machine perfusion versus static cold storage of kidneys donated after cardiac death: a UK multicenter randomized controlled trial.
    Watson CJ; Wells AC; Roberts RJ; Akoh JA; Friend PJ; Akyol M; Calder FR; Allen JE; Jones MN; Collett D; Bradley JA
    Am J Transplant; 2010 Sep; 10(9):1991-9. PubMed ID: 20883534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Cost-Effectiveness Analysis of Organ Preservation Methods for Deceased Donor Kidneys at High Risk for Delayed Graft Function in Brazil.
    Tedesco Silva H; Evans RW; Gavaghan MB; Vazquez VC
    Transplant Proc; 2018 Dec; 50(10):3121-3127. PubMed ID: 30577177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negative impact of prolonged cold storage time before machine perfusion preservation in donation after circulatory death kidney transplantation.
    Paloyo S; Sageshima J; Gaynor JJ; Chen L; Ciancio G; Burke GW
    Transpl Int; 2016 Oct; 29(10):1117-25. PubMed ID: 27421771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supplemental hydrogen sulphide protects transplant kidney function and prolongs recipient survival after prolonged cold ischaemia-reperfusion injury by mitigating renal graft apoptosis and inflammation.
    Lobb I; Mok A; Lan Z; Liu W; Garcia B; Sener A
    BJU Int; 2012 Dec; 110(11 Pt C):E1187-95. PubMed ID: 23157304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Hypothermic Machine Perfusion on the Preservation of Kidneys Donated After Cardiac Death: A Single-Center, Randomized, Controlled Trial.
    Wang W; Xie D; Hu X; Yin H; Liu H; Zhang X
    Artif Organs; 2017 Aug; 41(8):753-758. PubMed ID: 28176336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventing acute kidney injury during transplantation: the application of novel oxygen carriers.
    Thuillier R; Delpy E; Matillon X; Kaminski J; Kasil A; Soussi D; Danion J; Sauvageon Y; Rod X; Donatini G; Barrou B; Badet L; Zal F; Hauet T
    Expert Opin Investig Drugs; 2019 Jul; 28(7):643-657. PubMed ID: 31165652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxygenated End-Hypothermic Machine Perfusion in Expanded Criteria Donor Kidney Transplant: A Randomized Clinical Trial.
    Husen P; Boffa C; Jochmans I; Krikke C; Davies L; Mazilescu L; Brat A; Knight S; Wettstein D; Cseprekal O; Banga N; Bellini MI; Szabo L; Ablorsu E; Darius T; Quiroga I; Mourad M; Pratschke J; Papalois V; Mathe Z; Leuvenink HGD; Minor T; Pirenne J; Ploeg RJ; Paul A
    JAMA Surg; 2021 Jun; 156(6):517-525. PubMed ID: 33881456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HEMO
    Teh ES; Zal F; Polard V; Menasché P; Chambers DJ
    Artif Cells Nanomed Biotechnol; 2017 Jun; 45(4):717-722. PubMed ID: 28079401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypothermic machine perfusion of kidneys retrieved from standard and high-risk donors.
    Jochmans I; O'Callaghan JM; Pirenne J; Ploeg RJ
    Transpl Int; 2015 Jun; 28(6):665-76. PubMed ID: 25630347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normothermic machine perfusion versus static cold storage in donation after circulatory death kidney transplantation: a randomized controlled trial.
    Hosgood SA; Callaghan CJ; Wilson CH; Smith L; Mullings J; Mehew J; Oniscu GC; Phillips BL; Bates L; Nicholson ML
    Nat Med; 2023 Jun; 29(6):1511-1519. PubMed ID: 37231075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome Improvement for Hypothermic Machine Perfusion Versus Cold Storage for Kidneys From Cardiac Death Donors.
    Zhong Z; Lan J; Ye S; Liu Z; Fan L; Zhang Y; Fu Z; Qiao B; Shiu-Chung Ko D; Wang Y; Ye Q
    Artif Organs; 2017 Jul; 41(7):647-653. PubMed ID: 28703374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients.
    Jordan SC; Choi J; Aubert O; Haas M; Loupy A; Huang E; Peng A; Kim I; Louie S; Ammerman N; Najjar R; Puliyanda D; Vo A
    Am J Transplant; 2018 Dec; 18(12):2955-2964. PubMed ID: 29637714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for delayed graft function in cadaveric kidney transplantation: a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group.
    Koning OH; Ploeg RJ; van Bockel JH; Groenewegen M; van der Woude FJ; Persijn GG; Hermans J
    Transplantation; 1997 Jun; 63(11):1620-8. PubMed ID: 9197357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of Deceased Donor Kidney Transplantation Using Expanded Criteria Donor Kidneys Following Pulsatile Preservation.
    Basu A; Rosen LM; Tan HP; Fishbein J; Wu CM; Donaldson JB; Stuart S; Shah NA; McCauley J; Humar A; Shapiro R
    Cureus; 2019 Jul; 11(7):e5091. PubMed ID: 31523526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transplantation of kidneys from uncontrolled donation after circulatory determination of death: comparison with brain death donors with or without extended criteria and impact of normothermic regional perfusion.
    Demiselle J; Augusto JF; Videcoq M; Legeard E; Dubé L; Templier F; Renaudin K; Sayegh J; Karam G; Blancho G; Dantal J
    Transpl Int; 2016 Apr; 29(4):432-42. PubMed ID: 26606511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Organ donor management and delayed graft function in kidney transplant recipients: A multicenter retrospective cohort study.
    Cardinal H; Lamarche F; Grondin S; Marsolais P; Lagacé AM; Duca A; Albert M; Houde I; Boucher A; Masse M; Baran D; Bouchard J
    Am J Transplant; 2019 Jan; 19(1):277-284. PubMed ID: 30253052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.